Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(21)
Published: March 27, 2024
Fibrosis,
which
is
primarily
marked
by
excessive
extracellular
matrix
(ECM)
deposition,
a
pathophysiological
process
associated
with
many
disorders,
ultimately
leads
to
organ
dysfunction
and
poor
patient
outcomes.
Despite
the
high
prevalence
of
fibrosis,
currently
there
exist
few
therapeutic
options,
importantly,
paucity
in
vitro
models
accurately
study
fibrosis.
This
review
discusses
multifaceted
nature
fibrosis
from
viewpoint
developing
organ-on-chip
(OoC)
disease
models,
focusing
on
five
key
features:
ECM
component,
inflammation,
mechanical
cues,
hypoxia,
vascularization.
The
potential
OoC
technology
explored
for
better
modeling
these
features
context
studying
fibrotic
diseases
interplay
between
various
emphasized.
paper
reviews
how
organ-specific
are
modeled
platforms,
elements
included
existing
avenues
novel
research
directions
highlighted.
Finally,
this
concludes
perspective
address
current
gap
respect
inclusion
multiple
yield
more
sophisticated
relevant
an
format.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 23, 2025
Astragaloside
IV
(C
41
H
68
O
14
,
AS-IV)
is
a
naturally
occurring
saponin
isolated
from
the
root
of
Astragalus
membranaceus
widely
used
traditional
Chinese
botanical
drug
in
medicine.
In
recent
years,
AS-IV
has
attracted
considerable
attention
for
its
hepatoprotective
properties,
which
are
attributed
to
low
toxicity
as
well
anti-inflammatory,
antioxidant
and
antitumour
effects.
Numerous
preclinical
studies
have
demonstrated
potential
prevention
treatment
various
liver
diseases,
including
multifactorial
injury,
metabolic-associated
fatty
disease,
fibrosis
cancer.
Given
promising
growing
interest
research,
this
review
provides
comprehensive
summary
current
state
research
on
effects
AS-IV,
based
literature
available
databases
such
CNKI,
PubMed,
ScienceDirect,
Google
Scholar
Web
Science.
The
mechanisms
multifaceted,
encompassing
inhibition
inflammatory
responses,
reduction
oxidative
stress,
improvement
insulin
leptin
resistance,
modulation
gut
microbiota,
suppression
hepatocellular
carcinoma
cell
proliferation
induction
tumour
apoptosis.
Notably,
key
molecular
pathways
involved
these
include
Nrf2/HO-1,
NF-κB,
NLRP3/Caspase-1,
JNK/c-Jun/AP-1,
PPARα/FSP1
Akt/GSK-3β/β-catenin.
Toxicity
indicate
that
high
level
safety.
addition,
discusses
sources,
physicochemical
challenges
development
clinical
application
providing
valuable
insights
into
agent
pharmaceutical
nutraceutical
industries.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(5), P. 2992 - 2992
Published: March 5, 2024
It
is
well
known
that
extreme
heat
events
happen
frequently
due
to
climate
change.
However,
studies
examining
the
direct
health
impacts
of
increased
temperature
and
waves
are
lacking.
Previous
reports
revealed
heatstroke
induced
acute
lung
injury
pulmonary
dysfunction.
This
study
aimed
investigate
whether
exposure
fibrosis
explore
underlying
mechanisms.
Male
C57BL/6
mice
were
exposed
an
ambient
39.5
±
0.5
°C
until
their
core
reached
maximum
or
exhaustion
state.
Lung
was
observed
in
lungs
heat-exposed
mice,
with
extensive
collagen
deposition
elevated
expression
molecules,
including
transforming
growth
factor-β1
(TGF-β1)
Fibronectin
(Fn1)
(p
<
0.05).
Moreover,
epithelial–mesenchymal
transition
(EMT)
occurred
response
exposure,
evidenced
by
E-cadherin,
epithelial
marker,
which
downregulated,
whereas
markers
EMT,
such
as
connective
tissue
factor
(CTGF)
zinc
finger
transcriptional
repressor
protein
Slug,
upregulated
tissues
Subsequently,
cell
senescence
examination
levels
both
senescence-associated
β-galactosidase
(SA-β-gal)
staining
cycle
kinase
inhibitor
p21
significantly
Mechanistically,
cGAS–STING
signaling
pathway
evoked
DNA
damage
activated
In
summary,
we
reported
a
new
finding
contributed
development
early
fibrosis-like
changes
through
damage-activated
followed
cellular
senescence.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(21)
Published: March 27, 2024
Fibrosis,
which
is
primarily
marked
by
excessive
extracellular
matrix
(ECM)
deposition,
a
pathophysiological
process
associated
with
many
disorders,
ultimately
leads
to
organ
dysfunction
and
poor
patient
outcomes.
Despite
the
high
prevalence
of
fibrosis,
currently
there
exist
few
therapeutic
options,
importantly,
paucity
in
vitro
models
accurately
study
fibrosis.
This
review
discusses
multifaceted
nature
fibrosis
from
viewpoint
developing
organ-on-chip
(OoC)
disease
models,
focusing
on
five
key
features:
ECM
component,
inflammation,
mechanical
cues,
hypoxia,
vascularization.
The
potential
OoC
technology
explored
for
better
modeling
these
features
context
studying
fibrotic
diseases
interplay
between
various
emphasized.
paper
reviews
how
organ-specific
are
modeled
platforms,
elements
included
existing
avenues
novel
research
directions
highlighted.
Finally,
this
concludes
perspective
address
current
gap
respect
inclusion
multiple
yield
more
sophisticated
relevant
an
format.